LumiSTAR Biotechnology Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

LumiSTAR Biotechnology General Information

Description

Developer of cell therapies designed for neurodegenerative, kidney, inflammatory, and cancer-related conditions. The company utilizes high-throughput phenotypic screening, disease-modeling assays, and functional testing based on induced pluripotent stem cells and bioimaging-based screening technologies, enabling pharmaceutical researchers and clinicians to discover drug candidates and advance research efficiently.

Contact Information

Website
lumistarbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Number 99, Lane 130, Section 1
  • Yanjiuyuan Road, Nangang
  • Taipei, Nangang 115
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Number 99, Lane 130, Section 1
  • Yanjiuyuan Road, Nangang
  • Taipei, Nangang 115
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LumiSTAR Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 24-Feb-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
3. Accelerator/Incubator 14-Nov-2020 Completed Generating Revenue
2. Accelerator/Incubator 18-Oct-2020 Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view LumiSTAR Biotechnology’s complete valuation and funding history, request access »

LumiSTAR Biotechnology Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

LumiSTAR Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250134884-A1 Method and pharmaceutical composition for treating type ii diabetes Pending 26-Oct-2023
US-20250339443-A1 Method for treating or preventing calcium release-activated calcium channel or discoidin domain receptor 2 related disorders or conditions Pending 19-Jan-2023
EP-4629975-A1 Pharmaceutical composition for use in the treatment or prevention of calcium release-activated calcium channel or discoidin domain receptor 2 related disorders or conditions Pending 19-Jan-2023
WO-2024153190-A1 Pharmaceutical composition for use in the treatment or prevention of calcium release-activated calcium channel or discoidin domain receptor 2 related disorders or conditions Inactive 19-Jan-2023
JP-2026504858-A Pharmaceutical compositions for use in the treatment or prevention of calcium release-activated calcium channel or discoidin domain receptor 2-associated disorders or conditions Pending 19-Jan-2023 A61K31/538
To view LumiSTAR Biotechnology’s complete patent history, request access »

LumiSTAR Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LumiSTAR Biotechnology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
UC Berkeley School of Public Health Innovation Accelerator Program Accelerator/Incubator
RAPID-Health Accelerator/Incubator
International Biomedical Intelligence Accelarator Accelerator/Incubator Minority
Beyond BioMed Accelerator Accelerator/Incubator
Taipei Angels Angel Group Minority
To view LumiSTAR Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

LumiSTAR Biotechnology FAQs

  • When was LumiSTAR Biotechnology founded?

    LumiSTAR Biotechnology was founded in 2016.

  • Where is LumiSTAR Biotechnology headquartered?

    LumiSTAR Biotechnology is headquartered in Taipei, Taiwan.

  • What is the size of LumiSTAR Biotechnology?

    LumiSTAR Biotechnology has 37 total employees.

  • What industry is LumiSTAR Biotechnology in?

    LumiSTAR Biotechnology’s primary industry is Drug Discovery.

  • Is LumiSTAR Biotechnology a private or public company?

    LumiSTAR Biotechnology is a Private company.

  • What is LumiSTAR Biotechnology’s current revenue?

    The current revenue for LumiSTAR Biotechnology is .

  • Who are LumiSTAR Biotechnology’s investors?

    UC Berkeley School of Public Health Innovation Accelerator Program, RAPID-Health, International Biomedical Intelligence Accelarator, Beyond BioMed Accelerator, and Taipei Angels have invested in LumiSTAR Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process